Novalis Biotech
Ghent, Belgium · Pre-seed → Series A
Their stated focus (public profile)
Novalis Biotech is an early-stage venture capital fund focused on life sciences, with an emphasis on 'enabling technologies' including innovative research and manufacturing tools, bioinformatics, genomics, diagnostics, and digital health. The fund strongly believes in capital-light platform technology and close customer interaction from the earliest stages. It invests from pre-seed through Series A, supporting portfolio companies with funding, professional and academic connections, and business strategy development.
Stages: Pre-seed → Series A
Sectors: Life sciences, Healthtech, Computational biology, Medtech, Biomanufacturing
On file: 9 partners on record · 13 companies on record
Website: noval.is
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.